Navigation Links
Dow AgroSciences, China National Rice Research Institute Announce Collaboration on Rice Research
Date:2/17/2009

INDIANAPOLIS and HANGZHOU, China, Feb. 17 /PRNewswire-FirstCall/ -- Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), and the China National Rice Research Institute (CNRRI) of Hangzhou, China, announced today that they have entered into a research agreement to combine the strengths of Dow AgroSciences' platform of traits and technologies with CNRRI's leading rice germplasm.

"We look forward to working with CNRRI to introduce novel technologies in rice in China and the rest of the world to improve the productivity of one of the world's most important food crops and to help address the needs of our growing global population," said Daniel R. Kittle, Ph.D., vice president, R&D, Dow AgroSciences and Core Biotechnology for The Dow Chemical Company.

"We are confident that with Dow AgroSciences, a global leader in biotechnology, we will bring cutting edge technologies and innovative solutions to agriculture through this collaboration project," said Director General Cheng Shihua, Ph.D., China National Rice Research Institute.

About China National Rice Research Institute (CNRRI)

China National Rice Research Institute (CNRRI) is an integrative research institute of basic rice science in China. It was established in Hangzhou, Zhejiang Province as approved by the Chinese State Council in June 1981, under the dual leadership of Chinese Academy of Agricultural Sciences (CAAS) and the Zhejiang Provincial Government.

CNRRI focuses on basic and applicable researches with priority on solving significant scientific and technical problems in rice production. Engaging in rice research at population, individual, tissue, cell, and molecular levels, its mission is to contribute food security, nutrition improvement and environment protection.

About Dow AgroSciences

Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a top-tier agricultural company that combines the power of science and technology with the "Human Element" to constantly improve what is essential to human progress. Dow AgroSciences provides innovative technologies for crop protection, pest and vegetation management, seeds, traits, and agricultural biotechnology to serve the world's growing population. Global sales for Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, were $4.5 billion in 2008. Learn more at www.dowagro.com


'/>"/>
SOURCE Dow AgroSciences LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
2. Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry
3. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration
4. China Biologic Products High-Purity Human Albumin Research and Development Project to be Listed in the National Torch Plan
5. OriGene Technologies, Inc. Establishes High Throughput Monoclonal Antibody Production Outsourcing Center in China
6. China Biologic Products Receives High-Technology Enterprise Certification to Qualify for Preferential Income Tax Rate
7. China Pharma Holdings, Inc. Announces Clinical Trials Already Underway for Candesartan
8. China-Biotics, Inc. to Present at Roth Capital Partners 21st Annual OC Growth Stock Conference
9. Syngenta Enters Into Research Collaboration With Anhui Academy, China
10. China Sky One Medical, Inc. CFO to Present at Roth Conference
11. AMDL First to Implement US & China-Based, GAAP-Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... 2017 Aethlon Medical, Inc. (Nasdaq: ... that validated the ability of the Aethlon Hemopurifier® to ... mortality in immune-suppressed sepsis patients and also contribute to ... objective of the study was to validate the ... (EBV) and Herpes Simplex virus 1 (HSV1) by the ...
(Date:2/22/2017)... and RESEARCH TRIANGLE PARK, N.C., Feb. 22, 2017 /PRNewswire/ ... today announced its financial results for the fourth ... "Our annual 2016 financial results reflect continued growth ... exceeded $700 million," said Martine Rothblatt, Ph.D., United ... results strengthen our ability to develop and advance ...
(Date:2/21/2017)... ... 21, 2017 , ... Vortex Biosciences announced the ... benchtop system for collecting intact circulating tumor cells (CTCs) that are shed by ... Tri Conference (Tri-Con) Annual Meeting 2017 (February 19–24 San Francisco). , The ...
(Date:2/21/2017)... IL (PRWEB) , ... February ... ... of the Life -Sciences division, Treximo will pair its $200M operational capacity ... results-based consulting and project management in areas affecting quality and operational management. ...
Breaking Biology Technology:
(Date:1/24/2017)... , Jan. 24, 2017 Biopharm ... of the laboratory use of nuclear magnetic resonance ... experienced end-users and profiled current practices, developments, trends ... as well as growth and opportunities. These areas ... suppliers, NMR instruments, needs and innovation requirements, hyphenated ...
(Date:1/21/2017)... Research and Markets has announced the addition ... to their offering. ... The global voice recognition biometrics market to grow at a ... report covers the present scenario and the growth prospects of the ... size, the report considers the revenue generated from the sales of ...
(Date:1/18/2017)...  In vitro diagnostic (IVD) companies were very active ... and Kalorama Information expects that trend to continue – ... Generally, uncertainty in reimbursement and healthcare reform in ... the acquisitions landscape. Instead of looking to buy technology, ... outside of their home country and also to increase ...
Breaking Biology News(10 mins):